Weight Loss
    Timeline

    GLP-1 Weight Loss Slowing Down After 6 Months: Is It Normal?

    Yes, it is normal. Here is why weight loss naturally decelerates on semaglutide and tirzepatide, what to expect going forward, and when to take action.

    Last updated: April 1, 202616 min read

    For the first few months on semaglutide or tirzepatide, the scale seemed to drop effortlessly. Two pounds here, three pounds there -- sometimes five in a good week. Now, at the 6-month mark, progress has slowed to a crawl. Half a pound per week feels like nothing compared to the early days. Is the medication losing its effectiveness? Should you be worried? The short answer: this deceleration is completely normal, expected, and -- importantly -- does not mean the medication has stopped working.

    Understanding the Weight Loss Curve

    Weight loss on GLP-1 medications does not follow a straight line. It follows a curve -- steep at first, then gradually flattening. This pattern is consistent across all clinical trials and all weight loss interventions:

    Typical Weight Loss Timeline on GLP-1

    Months 1-3: Rapid Phase

    Average loss: 1.5-3 lbs/week. Accounts for ~40-50% of total weight loss. Driven by strong appetite suppression and initial metabolic advantage.

    Months 3-6: Active Phase

    Average loss: 1-2 lbs/week. Accounts for ~25-30% of total weight loss. Weight loss remains steady but noticably slower than initial phase.

    Months 6-12: Deceleration Phase

    Average loss: 0.5-1 lb/week. Accounts for ~15-20% of total weight loss. Progress feels slow but is still meaningful. Body composition continues improving.

    Months 12-18: Plateau/Maintenance Phase

    Weight stabilizes near a new equilibrium. Minimal additional loss. Goal shifts to maintaining achieved weight and optimizing body composition.

    Why Weight Loss Naturally Decelerates

    The slowing is not medication failure -- it is physiology. Several interconnected mechanisms drive deceleration:

    1. You Burn Fewer Calories at a Lower Weight

    A 250-pound person burns significantly more calories daily than a 200-pound person, even at rest. As you lose weight, your total daily energy expenditure (TDEE) decreases. A deficit that produced 2 lbs/week of loss at 250 lbs may only produce 0.5 lbs/week at 200 lbs because the gap between intake and expenditure has narrowed naturally.

    2. Metabolic Adaptation (Adaptive Thermogenesis)

    Your body responds to sustained calorie deficit by becoming more efficient. Non-exercise activity thermogenesis (NEAT) decreases -- you fidget less, move less spontaneously, and your body conserves energy in subtle ways. This can reduce daily expenditure by an additional 100-200 calories beyond what weight loss alone would predict.

    3. Hormonal Recalibration

    Leptin (satiety hormone) decreases as fat mass drops, reducing the fullness signal. Ghrelin (hunger hormone) may partially adapt to the medication's suppressive effects. Thyroid hormone output may slightly decrease to conserve energy. These hormonal shifts work to defend your body's current weight.

    4. Muscle Mass Changes

    If muscle has been lost during the first 6 months (especially without resistance training), your resting metabolic rate has declined more than weight loss alone would explain. Each pound of muscle lost reduces daily calorie burn by 6-10 calories. This compounds over time, narrowing the deficit.

    5. Behavioral Normalization

    Early in treatment, the appetite suppression is powerful and novel. Over time, you may unconsciously adapt -- slightly larger portions, more calorie-dense food choices, reduced attention to eating behaviors. This is not failure; it is the natural adjustment to a "new normal."

    What You Can Do About It

    1

    Recalibrate Expectations

    Losing 0.5-1 lb per week at month 6+ is excellent progress. That is still 2-4 lbs per month, or 12-24 lbs over the next 6 months. Do not dismiss this because it was faster before.

    2

    Increase Protein Intake

    If you were not prioritizing protein from the start, now is critical. Higher protein preserves muscle (and therefore metabolic rate) and has the highest thermic effect. Target 0.8-1.0g per pound of body weight.

    3

    Start or Intensify Resistance Training

    Resistance training counteracts metabolic adaptation by preserving or building muscle. If you are already lifting, increase weight or volume. This is the single most impactful change you can make at this stage.

    4

    Increase Daily Steps

    NEAT is one of the biggest variables in daily calorie expenditure. Push from 6,000 steps to 8,000-10,000 daily. This alone can create an additional 100-200 calorie deficit.

    5

    Track Food for a Reality Check

    A 7-day food log can reveal calorie creep that has accumulated imperceptibly. Many patients discover 200-400 extra calories per day from sources they were not counting.

    6

    Discuss Dose Adjustment

    If you are not at maximum dose, escalation may provide renewed appetite suppression. Discuss with your provider whether a dose increase is appropriate at this stage.

    Redefining Success at 6 Months

    At the 6-month mark, it is time to expand your definition of success beyond the scale:

    Non-Scale Victories to Celebrate

    • Blood pressure normalization
    • Improved HbA1c or fasting glucose
    • Better cholesterol and triglyceride levels
    • Reduced or eliminated medications for comorbidities
    • Improved energy and sleep quality
    • Better mobility and reduced joint pain
    • Improved mental health and confidence
    • Clothes fitting better

    Better Metrics to Track

    • Weekly average weight (not daily fluctuations)
    • Waist circumference (monthly)
    • Strength in the gym (progressive overload)
    • Progress photos (every 4 weeks)
    • Energy levels and mood (journal)
    • Lab work improvements (quarterly)
    • Body fat percentage (DEXA every 6 months)
    • Physical capabilities (stairs, walking distance)

    The Long-Term Perspective

    Clinical trial data shows that GLP-1 medications continue to provide benefit well beyond 6 months:

    • STEP 5 (Semaglutide, 2 years): Weight loss was maintained at ~15% through year 2 with continued treatment. Patients who stopped medication regained weight.
    • SURMOUNT-3 and -4 (Tirzepatide): Continued treatment maintained weight loss significantly better than placebo, reinforcing that ongoing therapy is the foundation of sustained results.
    • Cardiovascular outcomes (SELECT trial): Semaglutide reduced major cardiovascular events by 20%, a benefit that accumulates over years of treatment regardless of the rate of weight loss.

    The message is clear: even when weight loss slows or stops, continued GLP-1 treatment provides metabolic protection, cardiovascular benefit, and prevents regain. The medication is still working -- its role simply shifts from active weight loss to weight maintenance and metabolic health.

    Conclusion

    Weight loss slowing after 6 months on GLP-1 medications is a normal, expected physiological response -- not a sign that your medication has stopped working. Your body is reaching a new equilibrium at a lower weight, and the rate of loss naturally decelerates as the gap between calorie intake and expenditure narrows. By optimizing protein, adding resistance training, increasing daily movement, and shifting focus from scale velocity to overall health improvement, you can continue making meaningful progress.

    If you have significant remaining weight loss goals, discuss dose optimization or medication switching with your provider. But for many patients, the 6-month mark is an excellent time to shift focus from rapid loss to body composition improvement and long-term health gains. Learn more about our treatment options and how our program supports long-term success.

    Medical Disclaimer

    This article is for informational purposes only and does not constitute medical advice. Weight loss rates vary significantly between individuals. Consult your healthcare provider about your specific weight loss goals, medication management, and any concerns about treatment progress.

    Optimize Your Long-Term GLP-1 Results

    Trimi Health's medical team provides ongoing support and adjustments throughout your weight loss journey.

    Get Started Today

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 7, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Was this article helpful?

    Keep Reading

    Read our guide on Retatrutide Compounding Quality.

    When and how to start semaglutide or tirzepatide after pregnancy. Postpartum GLP-1 guide covering breastfeeding safety, timing, and realistic weight loss expectations.

    Buy compounded semaglutide online in Texas for $99/month. Learn about Texas telehealth laws, compounding pharmacy access, and how to start affordable GLP-1 weight loss treatment.

    Read our guide on Can Glp 1 Reduce Cancer Risk.